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Abstract
An estimated one in four transgender women (trans women) in the U.S. are infected with HIV. 
Rates of HIV testing are not commensurate with their risk, necessitating alternative strategies for 
early detection and care. We explored the feasibility and acceptability of HIV self-testing 
(HIVST) with 50 HIV-negative adult trans women in San Francisco. Participants received three 
self-test kits to perform once a month. Acceptability and behavioral surveys were collected as 
were 11 in-depth interviews (IDIs). Among 50 participants, 44 reported utilizing HIVST at least 
once; 94 % reported the test easy to use; 93 % said results were easy to read; and 91 % would 
recommend it to others. Most participants (68 %) preferred HIVST to clinic-based testing, 
although price was a key barrier to uptake. IDIs revealed a tension between desires for privacy 
versus support found at testing sites. HIVST for trans women was acceptable and feasible and 
requires careful consideration of linkage to support services.
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Introduction
Transgender women (individuals assigned a male sex at birth but who identify as female 
and/or transgender) represent the population most disproportionately impacted by HIV in the 
United States. Transgender women (trans women) have extremely elevated infection rates. 
Estimates from available data would indicate that over a quarter of trans women are infected 
[1–3], and infection rates may be twice as high among trans women of color [3, 4]. A 
systematic review of HIV prevalence among trans women in the U.S. estimated prevalence 
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at 28 % [5], with the prevalence among Black trans women reaching 56 %. These estimates 
surpass infection among men who have sex with men (MSM) and are well over 40 times 
higher than the estimated prevalence in the non-transgender (cis-gender) U.S. population 
[5]. Despite elevated risk for HIV, the rates of HIV antibody testing among trans women are 
significantly lower than other at-risk groups [6, 7]. It is estimated that fewer than half of 
HIV positive trans women know their status [5]. Because testing is the gateway into HIV 
care and treatment, the U.S. transgender population, estimated to be 700,000 people [8], 
urgently needs alternative approaches that facilitate access to HIV testing.
Among technologies that may facilitate access to testing for trans women and other 
marginalized and high risk groups, HIV self-testing (HIVST) has enormous potential to 
increase the proportion of people tested, increase testing frequency, and encourage earlier 
detection of HIV and thus earlier treatment [9]. Availability of HIVST can offer the 
transgender community an opportunity to test without being exposed to discrimination in the 
clinical setting. Extreme stigma and discrimination and fear of a positive result often 
discourage the trans population from seeking health or social services, including testing and 
treatment [10–12]. While the acceptability and feasibility of HIVST remains unexplored in 
trans communities, acceptability data among high risk MSM in the U.S. indicate a desire to 
self-test [13, 14], particularly among black MSM [15], suggesting that this strategy may 
appeal to, and even empower [16], high-risk groups with poor access to care and distrust of 
the health system.
In order to understand the potential of self-conducted HIV tests for trans women and 
strategies to ensure successful use and appropriate follow-up, we conducted a mixed-
methods feasibility and acceptability pilot study following 50 trans women in San Francisco 
for a 3-month period.
Methods
Study Procedures
Fifty trans women were recruited between June and August of 2013. Recruitment included 
utilization of the participant database at the Center of Excellence for Transgender Health 
(CoE) at the University of California San Francisco (UCSF), as well as recruitment flyers, 
Facebook postings at partnering agencies, and peer referral from participants. Eligible 
participants self-identified as transgender women (male sex assigned at birth, currently 
female identified), 18 years of age or older, sexually active (practicing anal sex in the past 
year), not known to be HIV infected, and willing and able to perform all study procedures. 
Eligibility screening was conducted by phone and then negative HIV status was confirmed 
by a certified HIV test counselor at the study site prior to provision of informed consent. 
Study visits were conducted at the UCSF Center for AIDS Prevention Studies offices in 
downtown San Francisco. The protocol was approved by the UCSF Committee for Human 
Research.
Consenting participants were enrolled for a 3-month time period, asked to conduct HIVST 
on a monthly basis, and to attend study visits at enrollment, 1 month, and 3 months. At 
enrollment, participants underwent trans-competent HIV counseling and testing with a 
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trained counselor. The counselor conducted HIV testing with the Clearview® HIV 1/2 
STAT-PAK (Chembio Diagnostics Systems, Inc, Medford, NY), according to 
manufacturer’s instructions. Participants then completed an interviewer-administered 
behavioral survey including questions regarding demographics, sexual and other risk 
behaviors, health care utilization, HIV testing history, social support, and perceived 
experiences of discrimination and stigma. Following the survey, study staff provided 
training on use of the OraQuick In-Home HIV tests™ [OraSure Technologies, Inc., 
Bethlehem, PA], an oral fluid test approved by the US Food and Drug Administration (US 
FDA) for over-the-counter sales [17]. Training for HIVST included a demonstration and 
walk-through of the kit instructions. Participants were provided with a self-test kit and a 
testing log to record the date, location, and test results. Kits included written instructions, 
pre- and post-test counseling materials, a list of local HIV/AIDS and related resources for 
trans women, referrals for confirmatory testing, and condoms and lubrication sachets.
Participants returned for a follow-up visit at 1 month to complete a brief acceptability 
survey, review testing procedures if further instruction was needed or requested, drop off 
their testing log, collect two additional testing kits and logs, and schedule a final follow-up 
appointment for 2 months later. Participants were asked to conduct their self-tests during the 
second and third month of follow-up, prior to coming in for their final study visit. The final 
study visit also included completion of a behavioral survey. After the first follow-up visit, a 
subsample of participants (n = 15) were selected to complete a semi-structured in-depth 
interview (IDI). IDI participants were sampled purposefully for racial/ethnic representation 
and to include participants who reported using the test with others and/or difficulty doing the 
test, to ensure we captured a variety of experiences. Among those selected, 11 completed the 
second follow-up visit as well as the IDI. Interview topics included self-testing experiences; 
facilitators and barriers to HIVST; testing decisions and contexts (e.g. choosing to test with 
a partner or friend); experiences using study resources; concerns about test use; interest in 
future self-testing; and suggestions for optimal delivery and entry into care. IDIs were 
audio-recorded, transcribed, and coded for analysis in Atlas.ti.
Measures
Acceptability surveys included questions regarding the number of self-tests participants 
performed themselves (and if any tests were used to test partners or friends), ease of using 
the tests and interpreting test results, confidence in results, willingness to test again and/or 
recommend the test, and preferences for future testing and testing venue. Future testing 
preference was assessed by asking participants to select whether they would like their next 
HIV test to be conducted by a health professional or if they would prefer to test themselves, 
or if they had no preference. Similarly, participants were asked how they would prefer to 
receive future HIV test results: from someone who would provide results and counseling, by 
reading the results themselves, or no preference. Demographic and behavioral indicators 
were tailored to trans women based on previous research conducted at the UCSF CoE. 
History of sex work was determined by participant’s response to the question “have you 
ever engaged in sex work or prostitution, where someone paid you money or gave you 
something like drugs, food, clothes, or housing in return for sex?” Intimate Partner Violence 
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(IPV) was measured using a scale adapted and validated by Brennan et al. [18] to capture 
experiences of IPV specific to trans women.
Data Analysis
Questionnaire data were entered directly into REDCap [19] and analyzed with STATA 
version 13 (Stata Statistical Software: Release 13. College Station, TX: StataCorp LP). 
Frequency tables were generated to describe the population demographics, testing uptake, 
and acceptability of the test kits. Bivariate analysis included use of Chi square tests for 
binary predictors and nonparametric, rank-sum tests for continuous variables to explore 
associations between participant characteristics and test utilization patterns (number of tests 
used and using tests with others) and testing preferences. We also explored whether any 
demographic or behavioral characteristics predicted testing preferences longitudinally using 
generalized estimating equations (GEE) with a log-link function to account for within-par-
ticipant correlation when estimating regression parameters. We were unable to explore 
whether changes in condom use behaviors occurred following test kit utilization due to the 
small sample size, with only 27 participants who reported on condom use at both the 
baseline and final visit.
We used a template analysis framework to code qualitative interview data [20], generating 
an initial list of themes or deductive codes based on the interview topics and applying these 
codes to the data using Atlas.ti (version 7.1.8, Scientific Software Development GmbH, 
Berlin). Based on review of the deductively coded data, inductive codes were used to flag 
data on themes that emerged within or across the topics. Coding was primarily done by one 
reviewer (SC) following an independent coding exercise (SC, LM), and generating 
consensus around a single coding framework. Using code reports, the team discussed the 
main ideas that emerged, and explored and charted relationships within the data among 
themes [21, 22]. Once quantitative and qualitative analyses were completed separately, 
findings from the two data sources were triangulated to check for inconsistencies and 
patterns between and among findings. Pseudonyms are used to present quotes from 
qualitative findings.
Results
Of 90 potential participants screened for eligibility, 17 were not eligible (1 identified as 
male, 2 were underage, 2 were assigned female sex at birth, 2 were not willing to test for 
HIV, 6 were HIV positive, and 4 were not sexually active). Among the 73 (81 %) who were 
eligible, 10 participants declined to participate, 12 scheduled an appointment but did not 
present at the study site, and 51 participants (70 % of those eligible) were enrolled. One 
participant was later determined ineligible (was not trans-gender), leaving 50 participants for 
analysis. Those who did not present for their appointment or declined to participate were of 
similar ethnic/racial background as the study participants.
Quantitative data results
Participant age ranged from 22 to 63 years old; median age was 42 years (inner quartile 
range 28–49); 70 % were over 30 years old. Thirty percent identified as Black/African 
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American, 22 % as White/Caucasian, 20 % as Hispanic/ Latino, 8 % as Asian/Pacific 
Islander, 8 % as Native American, and 12 % as multi-racial (Table 1). Just over half (56 %) 
had some form of post high-school education, and just under half (48 %) reported not 
working or receiving some form of public assistance. Eighty percent of participants reported 
that at some point in the previous year they did not earn enough money to cover daily living 
expenses (e.g., food, rent), with just under half of the population reporting having been 
homeless at some time in the past year. Sixty-eight percent had a history of arrest or 
incarceration.
Almost all participants reported having multiple sexual partnerships in the past 3 months (96 
%) and low rates of consistent condom use (28 % with main partners/44 % with other 
partners). Eighty-two percent had ever engaged in sex work. Seventy-six percent reported 
having experienced some form of interpersonal violence or abuse in the past, including 46 % 
who reported sexual violence by a partner. Despite reporting indicators of social 
marginalization, participants were well-connected to testing and health-related services. All 
participants reported seeing a healthcare provider in the past year, 74 % reported being 
comfortable in healthcare settings, but 46 % also reported ever needing to see a provider and 
not going. Ninety-six percent of participants had been tested for HIV prior to participating in 
this study; 88 % had tested within the past year. None of the participants had ever used a 
self-test prior to participation.
Of the fifty participants who completed the baseline visit, 44 (88 %) returned for one-month 
follow-up and 36 (72 %) returned for the final three-month follow-up (Fig. 1). All of the 44 
participants who returned for the first follow-up appointment reported using a self-test; 
though one later indicated during an IDI that she gave the first test kit to a friend but utilized 
test kits prior to her second visit. At the second follow-up visit all 36 participants (86 %) 
indicated using two or more of the HIV self-testing kits, with four participants indicating 
that they gave a test kit to friends or partners to use. No seroconversions were documented 
during the study; given the short follow-up period in this study and the known window 
period of the Ora-Quick test, detecting a seroconversion was unlikely. Further, it is unknown 
whether participants who were lost to follow-up used their test kits or seroconverted.
Across the visits, just over a quarter of the participants (n = 13) reported using the kit with 
another person present. In bivariate analysis, there were no socio-demographic or behavioral 
characteristics associated with increased uptake of self-testing (2–3 tests vs. 1 or none, Table 
1). Indicators of lower SES, including being out of work and having insufficient income, 
were significantly associated with performing the self-test with someone else present. 
Having fewer lifetime partners was also associated with testing with others present. Lower 
education level (high school or less compared to at least some college or more) was the only 
covariate significantly associated with ever stating a preference for self-testing.
At the one-month follow-up visit, 95 % of participants reported that it was easy to use 
HIVST; the two participants who indicated difficulties cited emotional difficulties (i.e. 
feeling nervous or anxious about the result) rather than technical difficulties when 
explaining their responses (Table 2). Additionally, 91 % of participants reported that it was 
easy to follow the instructions that were included in the test kit, with only one person 
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explaining that they did not understand much of the language that was used. Ninety-three 
percent of participants indicated that it was easy to interpret the test results; of those who 
reported difficulty interpreting the results, two cited an indeterminate result. Furthermore, 98 
% of participants reported feeling confident they used the tests correctly. Additionally, at the 
one-month follow-up, 68 % stated they would prefer HIV self-tests vs clinic-based HIV tests 
in the future. Similarly, when asked how they would prefer to receive HIV test results, 64 % 
of participants stated they would prefer to read results alone. Ninety-one percent indicated 
they would recommend the self-test to others. Finally, preferences for distribution of test kits 
were reported as follows: pharmacy (39 %), pick-up from clinic (27 %), pick-up from local 
CBO (18 %), online with home delivery (14 %), and no preference (2 %).
Testing preferences did not change significantly over time: three people who had stated 
preference for self-testing at the first follow-up stated preference for clinic-based testing at 
second follow-up and one changed from clinic-based to self-testing preference. No 
demographic or behavioral characteristics were significantly associated with preference for 
self-testing vs clinic-based or no testing preference in longitudinal analyses (data not 
shown).
Qualitative Data Results
Eleven participants discussed their HIV self-testing experiences during in-depth interviews 
(IDIs). IDI participant demographics mirrored the overall sample, with age ranging from 22 
to 63 years and the same approximate proportions of race/ethnicity and education level 
represented. All but one of the IDI participants used an HIV self-test kit, with 9 of the 11 
using two or more tests. Four participants gave test kits to friends and/or used them to test 
partners.
Results from IDIs demonstrated that self-tests were generally acceptable to our participants; 
the tests were easy to use, convenient, and painless. Other than requests that the packaging 
be smaller and more discrete, participants did not report dissatisfaction with any elements of 
the test.
“To be honest my experience was the test was very convenient. I liked it. I liked 
how easy it was for the most part. The liquid part kind of scared me a little. That 
was the only part though. And making sure I used around the gums correctly, but 
other than that I think all in all my experience was rewarding in the fact that it was 
convenient and also accurate.” (Lila, age 22)
The greatest barrier participants identified to future test use was cost, which was described 
as a zero-sum factor: if the tests are either low- or no-cost, then testing preferences would 
inform the choice to use self-tests in the future. However, if tests are expensive past the 
point of accessibility, preferences were no longer a factor—participants would simply not 
purchase self-tests. When asked under what circumstances one would choose a self-test or 
choose to test at a clinic in the future, one participant said:
“Respondent: The circumstance is having to go and pay for them - the home test kit 
- and it’s free at a clinic to do…. [Interviewer: Okay, if costs were not an issue 
which would you prefer?] …The home kit.” (Ruby, age 47)
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Another participant concurred that trans women could not buy the test:
“Buy it? I don’t think so. It’s too expensive and we are a poor community. We need 
the money. [Interviewer: If it were a lower cost, would the trans women you know 
use it?] … Oh, yes… it’s an acceptable test, I trust the test, and it’s not going to be 
expensive…. Right now, I cannot afford it.” (Liana, age 60)
Overwhelmingly, those asked how much they would be willing to spend on a self-test said 
$20 or under, even though $20 was still described as a lot of money. Participants reported 
having easy access to free testing, sometimes receiving incentives to get tested at 
community-based organizations (CBOs). One participant explained her testing options and 
why $20 seemed like a reasonable price point, highlighting the economic context of testing 
in San Francisco:
“Because it’s $20. It’s not - it’s not like oh, you have to pay 100 dollars for this. 
Because then I would have gone to a clinic. And sometimes with clinics they 
provide incentives for coming in. You know, so sometimes that kind of determines 
where I go to test. And I’ll admit, like yeah, I have gone to get tested just for the 
incentive.” (Marie, age 24)
The interviews also provided a more nuanced view of what participants liked about self-
testing. In addition to convenience and privacy, some participants found it empowering that 
they could test themselves, particularly amidst relationships and social dynamics in which 
they did not always hold power.
“I think sometimes we are such a high risk group of women because sometimes 
we’re too trusting of [our partners]. You know, we let them sing us a song and we 
fall in love with it and that idea and then boom. … I think [self-testing] takes 
ownership in you knowing your status. And I think it, for me, makes me even more 
inclined to get tested more regularly.” (Desiree, age 23)
Three participants reported using self-tests provided by the study to test partners, and nearly 
all of the women interviewed expressed interest in partner testing. Some women liked both 
the idea that concurrent partner testing could offer support and that a potential partner 
refusing to test in front of you might be a red flag. In that sense, some of the participants 
referred to using self-tests to inform sexual decision making.
“If the person wouldn’t take the test with me, if I had more than one test and I had a 
prospect, there would be nothing happening with the penis intimately.” (Sheila, age 
63)
“ …you’re telling me you’re negative and you refuse to sit down and test, you’re 
lying to me.” (Brittany, age 49)
Participants also contrasted the privacy of the self-test with the public experience of clinic-
based testing. While 26 % of participants (13/50) reported feeling uncomfortable in health 
care settings in the surveys, only a few IDI participants reported a reluctance to go to a clinic 
due to fear of mistreatment by health professionals. Instead, many more described 
discomfort with being seen at a testing clinic by people they knew out of fear of gossip and 
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loss of privacy. This discomfort was fueled by perceptions of stigma both internal and 
external to the LGBT community.
“At the clinic, of course everybody is there, you’re nervous, people run and they 
see you. ‘Oh.’ They start thinking, especially in my community. ‘Oh, you know, 
she came to the STD clinic. Oh.’ And stuff like that, and start coming out with 
different ideas.” (Dora, Age 41)
Interviews also revealed that concern about stigma, and the related desire for the privacy, 
exists in tension with the desire for social and resource support. Participants spoke of the 
importance of privacy in their own lives and the lives of other trans women they knew, and 
over half (7/11) of those participating in IDIs stated explicitly that they associate clinic-
based testing with compromised privacy. However, all but one of those participants also 
reported that if they felt unsure of their status and could be positive, they would either want 
the resource support of a counselor in a clinic environment or the presence of a support 
person while self-testing.
“I could see someone comforting me if I did test positive. You know, I would be 
processing it. I’m sure they’d be like, ‘It’s OK,’ you know, et cetera. But who’s to 
say that, in a different circle of girls, that it doesn’t come up, ‘Oh, girl, I was just 
with Desiree and she, you know, tested positive and you know, I don’t know what 
she’s going to do,’ you know what I mean? I’ve seen it happen. And so, I just don’t 
know if I would [take that chance].” (Desiree, age 23)
Participants expressed an internal conflict in the decision-making process: the trade-off 
between support and privacy is particularly acute when social resources are low and the fear 
of stigma both from within and outside one’s own community are high. The need for support 
was highlighted in interviews not only as a function of context (HIV testing), but also as a 
need specific to trans women.
“A transgender’s life can be a lonely life. If you have the possibility of having 
some kind of emotional support, it helps a lot…. We do everything by ourselves 
because within the homosexual matrix, there are still prejudices.” (Sheila, Age 63)
Discussion
To our knowledge, this is the first study to explore acceptability and feasibility of self-
conducted HIV testing among trans women. Study participants used the tests, most more 
than once, and the majority indicated that the tests were easy to use and they would use them 
again. More than half stated a preference for self-testing over clinic-based testing. These 
results are similar to findings from other groups at high risk of HIV [23–25].
Approximately a quarter of the participants decided to provide tests to others or test with 
others, though participants were neither instructed to test with others nor explicitly 
instructed not to. In fact, testing together was often cited in qualitative interviews as an 
incentive for partners to discuss HIV and provide mutual support. In light of the desire to 
test in partnerships documented in the qualitative data, it is not surprising that survey data 
demonstrated that those with fewer lifetime partners (and thus potentially more 
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monogamous relationships) were also more likely to test with others. Self-conducted testing 
in partnerships or among friends could prove an important strategy to extend testing uptake 
overall. Currently, the OraQuick self-test is being packaged and marketed not as a 
partnership experience, but as an individual experience focused on privacy. While privacy is 
an important feature of the self-testing option, there may be an opportunity to package kits 
in pairs, which would allow for a single purchase to cover either two partners or to cover a 
follow-up test for repeat individual testing following the immunological window period. Our 
data reveal that the current individual self-test packaging approach might fail to capture a 
substantial population seeking to experience self-testing with a partner. For a population that 
experiences marginalization based on sexual identity and partnership choices, having the 
choice to test with a partner or a friend outside of potentially stigmatizing clinic sites is 
important. Even for those participants who were unsure what testing option they would 
choose in the future, a high level of interest in testing with a partner was expressed in the 
qualitative interviews and merits future exploration.
The conflict in choosing between professional support and privacy when testing alone 
reveals a key tension in decision making around self-testing for trans women. Self-testing 
may appeal to those who prioritize privacy; however participants also widely expressed a 
need for support when testing, particularly if they suspected seroconversion. Need for 
privacy was also extensively discussed in the context of a participants’ concern with stigma, 
particularly testing-related stigma from within the transgender community. In fact, fear of 
stigma and gossip within the transgender community seemed to deter trans women from 
presenting at clinics more so than fears of provider-based stigma, which were low in this 
population who reported being comfortable in health care environments. When asked about 
future testing preferences in qualitative interviews, participants struggled to reconcile the 
need for privacy and support when imagining their next testing experience.
As this study was the first exploration of HIVST acceptability and feasibility for trans 
women, it was designed to be small and exploratory and was not powered to detect 
differences in usage and preference by population characteristics, though patterns and trends 
that can shed light on these differences were explored nonetheless. There was substantial 
attrition in this study; however, we do not believe this reflects a disinterest or dissatisfaction 
with the HIV self-testing experience. Instead, this population is quite transient (at least four 
of fifty participants reported moving out of the study area in a period of three months), and 
some attrition was likely due to the study location—the financial district of San Francisco 
can be intimidating. The demographic profile of the participants reflected social and 
economic marginalization found in existing literature on U.S. trans women [26, 27], though 
our study participants were well-connected to testing and engaged in health-related services. 
This is likely due to the study environment of San Francisco, which offers a variety of health 
care options serving the transgender community, and has been providing comprehensive 
safety net health insurance for many years. Additionally, the majority of our participants (60 
%) were identified from study databases and community-based organizations or health 
clinics, indicating a sample population that is likely more linked with available clinical 
resources than transgender populations in areas without these networks [27]. Participants in 
this pilot were also HIV negative and aware of their status, having been tested at their 
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enrollment visit. As a result, we cannot draw conclusions about test acceptability among 
trans women unaware of their status or who had not undergone recent testing.
Conclusion
Twenty-five years of HIV prevention research, practice, and policy have not adequately 
produced evidence-based, effective prevention options for trans women, a population at 
disproportionately high risk for HIV. Instead, trans women have often been subsumed in 
efforts tailored for MSM, which may not be culturally appropriate for trans women who face 
unique barriers to care and distinctive contextual vulnerabilities [28–31]. As a result, little 
research has been conducted to support needed alternative testing strategies for trans 
women. We found that HIVST is a feasible strategy to expand the mix of testing options in 
this population, particularly for those who prefer to avoid the clinic environment and/or who 
require more frequent testing. To increase the potential for HIVST utilization among trans 
women, outreach is needed to inform this population about self-testing and enhanced 
opportunities for partner testing and strategies to facilitate linkage to social and resource 
support should be sought. Critically, the current price point may exclude populations that 
experience disproportionate economic marginalization; cost reduction or subsidization 
should be explored in the public health sector. Additional research should focus on 
expanding outreach, delivery options and implementation strategies to meet the testing 
needs of trans women and whether introduction of HIVST has the potential to improve early 
HIV diagnosis.
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Fig. 1. 
Participant recruitment, enrollment, and retention
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Table 2
Self-Testing acceptability and feasibility at first follow-up visit among transgender women participating in a 
study of self-conducted HIV testing, San Francisco, 2013–2014
Acceptability & feasibility items* Total (n = 44)
n %
Ease of collecting sample
  Easy to collect 42 95
  Difficult to collect 2 5
Ease of following instructions
  Easy to follow instructions 40 91
  Difficult to follow instructions 4 9
Ease of interpreting results
  Easy to interpret results 41 93
  Difficult to interpret results 3 7
Confidence in correct test use
  Confident 43 98
  Not confident 1 2
Preference for next HIV testing experience
  Prefer home/self-test 30 68
  Prefer to test with a health professional or no preference 14 32
Preference for receiving HIV test results
  Prefer to read tests alone 28 64
  Prefer to have someone present or no preference 16 36
Recommend HIV self-test to a friend/partner
  Yes 40 91
  No/Don’t know 4 9
*As reported at first follow-up visit
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